Platelet aggregation and chlorpromazine therapy.
Open Access
- 1 December 1978
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 6 (6) , 538-540
- https://doi.org/10.1111/j.1365-2125.1978.tb00881.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- CHARACTERIZATION OF RECEPTORS MEDIATING 5‐HYDROXYTRYPTAMINE‐ AND CATECHOLAMINE‐INDUCED PLATELET AGGREGATION, ASSESSED BY THE ACTIONS OF α‐ AND β‐BLOCKERS, BUTYROPHENONES, 5‐HT ANTAGONISTS AND CHLORPROMAZINEBritish Journal of Pharmacology, 1978
- PLASMA NORADRENALINE AND ADRENALINE CONCENTRATIONS AND DOPAMINE-BETA-HYDROXYLASE ACTIVITY IN PATIENTS WITH SHOCK DUE TO SEPTICEMIA, TRAUMA AND HEMORRHAGE1978
- The Biochemical High-Risk Paradigm: Behavioral and Familial Correlates of Low Platelet Monoamine Oxidase ActivityScience, 1976
- The ralationship between changes in 5‐HT induced platelet aggregation and clinical state in patients treated with fluphenazine.British Journal of Clinical Pharmacology, 1976
- INCREASED PLATELET AGGREGATION IN PATIENTS RECEIVING CHLORPROMAZINE: RESPONSES TO 5‐HYDROXYTRYPTAMINE, DOPAMINE AND N‐DIMETHYL DOPAMINEBritish Journal of Clinical Pharmacology, 1976
- Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine.Published by Wiley ,1975
- Membrane Active Drugs and the Aggregation of Human Blood PlateletsNature, 1967